← Leaderboards
Nagalakshmi Nadiminty
University Of California At Davis
$524,556
Attributed
$524,556
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $277.1K · FY2016–18$500K$375K$250K$125K$0
'16
'17
'18
Funding mix
By agency
NIH$524,556 · 2
By mechanism
R21$371,056 · 1
R03$153,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California At Davis
Same institution · by research overlap
- Allen C Gao$13,767,104
- Hongwu Chen$9,989,556
- Pui-Kai Li$1,169,912
- Valentina Medici$5,753,151
- Daniel Kiden Nishijima$2,542,904
Others in their field
Top investigators on “Public Health”
- David R. Weir · University Of Michigan At Ann Arbor$416,847,438
- Jeffrey P Krischer · University Of South Florida$337,395,475
- Wafaa M. El-Sadr · Columbia University Health Sciences$336,205,398
- Elisabeth H Lyman · California St Dept Of Hlth Srvs-Sacramen$325,795,604
- Myron S Cohen · Family Health International$295,773,363
- George R Seage · Abt Associates, Inc.$292,142,010
Research focus
Public HealthOncogenesProstate Cancer CellMalignant Neoplasm Of ProstateMicrornasNext GenerationFeedbackMalignant NeoplasmsGenerationsInnovationAndrogen AntagonistsMessenger RnaBindingMortalityEffective TherapyChemotherapyFamilyExhibitsAntiandrogen TherapyGene ExpressionAmericanIncidenceCastrationRegulation
Grant awards (4)
Alteration of the miR-let-7c:Lin28 ratio as a predictor of therapy resistance in Prostate Cancer$76,750
R03 · FY2018 · CA · contact PI
MicroRNAs Modulate Therapy Resistance in Prostate Cancer$200,318
R21 · FY2017 · CA · contact PI
Alteration of the miR-let-7c:Lin28 ratio as a predictor of therapy resistance in Prostate Cancer$76,750
R03 · FY2017 · CA · contact PI
MicroRNAs Modulate Therapy Resistance in Prostate Cancer$170,738
R21 · FY2016 · CA · contact PI